Day One Biopharmaceuticals, Inc.
NASDAQ:DAWN
16.39 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 422.765 | 239.616 | 270.391 | 230.784 | 241.179 | 189.211 | 49.268 | 85.262 | 120.864 | 388.877 | 262.731 | 284.309 | 297.16 | 309.996 | 154.87 | 43.728 |
| Short Term Investments
| 135.618 | 122.25 | 47.553 | 135.563 | 164.359 | 253.671 | 268.911 | 257.007 | 253.477 | 5.987 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 558.383 | 361.866 | 317.944 | 366.347 | 405.538 | 442.882 | 318.179 | 342.269 | 374.341 | 394.864 | 262.731 | 284.309 | 297.16 | 309.996 | 154.87 | 43.728 |
| Net Receivables
| 8.695 | 9.136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 2.735 | 0.151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.446 | 12.005 | 8.09 | 2.352 | 2.225 | 0.781 | 0.782 | 1.006 | 0.946 | 0.839 | 0.398 | 1.015 | 0.173 | 0.174 | 3.885 | 1.343 |
| Total Current Assets
| 580.996 | 383.158 | 326.034 | 375.274 | 405.538 | 449.784 | 322.388 | 347.874 | 380.513 | 402.503 | 267.368 | 289.368 | 303.311 | 316.025 | 158.755 | 45.071 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 3.478 | 0.36 | 0.444 | 0.56 | 0.655 | 0.713 | 0.688 | 0.719 | 0.899 | 1.06 | 0.246 | 0.284 | 0.335 | 0.386 | 0.435 | 0.483 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 16.216 | 16.802 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 16.216 | 16.802 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.117 | 0.117 | 0.167 | 0.214 | 7.986 | 0.259 | 0.487 | 0.469 | 0.449 | 0.484 | 0.165 | 0.169 | 0.137 | 0.126 | 1.69 | 0.107 |
| Total Non-Current Assets
| 19.811 | 17.279 | 0.611 | 0.774 | 8.641 | 0.972 | 1.175 | 1.188 | 1.348 | 1.544 | 0.411 | 0.453 | 0.472 | 0.512 | 2.125 | 0.59 |
| Total Assets
| 600.807 | 400.437 | 326.645 | 376.048 | 414.179 | 450.756 | 323.563 | 349.062 | 381.861 | 404.047 | 267.779 | 289.821 | 303.783 | 316.537 | 160.88 | 45.661 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 3.017 | 6.444 | 4.78 | 2.576 | 3.391 | 4.565 | 4.657 | 0.26 | 3.973 | 0.439 | 0.701 | 1.744 | 0.683 | 0.348 | 0.686 | 0.202 |
| Short Term Debt
| 0.077 | 0.19 | 0.3 | 0.408 | 0.437 | 0.428 | 0.417 | 0.405 | 0.462 | 0.427 | 0.171 | 0.204 | 0.202 | 0.201 | 0.199 | 0.198 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 1.462 | 0 | 0 | 25.483 | 20.238 | 19.333 | 0 | 0 | 0 | 11.772 | 0 | 6.605 | 4.976 | 4.019 | 2.174 | 1.569 |
| Other Current Liabilities
| 35.189 | 87.072 | 24.759 | 1.041 | 0.409 | 0.186 | 17.774 | 15.95 | 13.836 | 11.933 | 7.304 | 0.104 | 0.185 | 0.094 | 0.007 | 0.027 |
| Total Current Liabilities
| 39.745 | 93.706 | 29.839 | 29.508 | 24.475 | 24.512 | 22.848 | 16.615 | 18.271 | 12.799 | 8.176 | 8.657 | 6.046 | 4.662 | 3.066 | 1.996 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 2.538 | 0 | 0 | 0 | 0.077 | 0.19 | 0.3 | 0.408 | 0.514 | 0.617 | 0 | 0.016 | 0.065 | 0.112 | 0.159 | 0.204 |
| Deferred Revenue Non-Current
| 3.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -3.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.872 | -0.016 | 0 | 0 | 221.721 | 91.964 |
| Total Non-Current Liabilities
| 5.599 | 0 | 0 | 0 | 0.077 | 0.19 | 0.3 | 0.408 | 0.514 | 0.617 | 0.872 | 0.016 | 0.065 | 0.112 | 221.88 | 92.168 |
| Total Liabilities
| 45.344 | 93.706 | 29.839 | 29.508 | 818.253 | 24.702 | 23.148 | 17.023 | 18.785 | 13.416 | 8.176 | 8.673 | 6.111 | 4.774 | 224.946 | 94.164 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 303.783 | 0 | 4.783 | 0 |
| Common Stock
| 0.01 | 0.009 | 0.009 | 0.009 | 0.009 | 0.009 | 0.007 | 0.007 | 0.007 | 0.007 | 0.006 | 0.006 | 0.006 | 0.006 | 2 | 2 |
| Retained Earnings
| -488.367 | -525.404 | -520.997 | -458.585 | -404.074 | -357.924 | -312.061 | -269.668 | -229.559 | -191.764 | -155.234 | -127.487 | -105.548 | -86.308 | -72.024 | -56.842 |
| Accumulated Other Comprehensive Income/Loss
| -0.006 | -0.022 | -0.005 | 0.009 | -0.007 | -0.009 | 0.067 | -0.071 | -0.392 | -0.003 | 0 | 0 | -303.783 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,043.826 | 832.148 | 817.799 | 805.107 | -0.002 | 783.978 | -0.074 | 601.771 | 593.02 | 582.391 | 414.831 | -0.006 | 403.214 | 398.065 | -3.608 | 0.637 |
| Total Shareholders Equity
| 555.463 | 306.731 | 296.806 | 346.54 | -404.074 | 426.054 | -312.061 | 332.039 | 363.076 | 390.631 | 259.603 | -127.487 | 297.672 | 311.763 | -68.849 | -54.205 |
| Total Equity
| 555.463 | 306.731 | 296.806 | 346.54 | -404.074 | 426.054 | -312.061 | 332.039 | 363.076 | 390.631 | 259.603 | -127.487 | 297.672 | 311.763 | -68.849 | -54.205 |
| Total Liabilities & Shareholders Equity
| 600.807 | 400.437 | 326.645 | 376.048 | 414.179 | 450.756 | -288.913 | 349.062 | 381.861 | 404.047 | 267.779 | -118.814 | 303.783 | 316.537 | 160.88 | 45.661 |